Skip to main content
main-content
Erschienen in: Allergo Journal 5/2022

25.07.2022 | Im Fokus

Weisheiten aus dem Weißbuch - Kapitel 4.6

Pharmakotherapie bei allergischer Rhinitis und Asthma bronchiale

verfasst von: Prof. Dr. med. Ludger Klimek

Erschienen in: Allergo Journal | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Auszug

In diesem Kapitel aus der Neuauflage des "Weißbuch Allergie in Deutschland" gibt Prof. Ludger Klimek einen Überblick über die medikamentösen Behandlungsmöglichkeiten, die für Patienten mit allergischer Rhinitis und Asthma bronchiale zur Verfügung stehen.
Literatur
1.
Zurück zum Zitat Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76 Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76
2.
Zurück zum Zitat Khan MA, Abou-Halawa AS, Al-Robaee AA, Alzolibani AA, Al-Shobaili HA. Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial. J Laryngol Otol 2010;124:397-401 Khan MA, Abou-Halawa AS, Al-Robaee AA, Alzolibani AA, Al-Shobaili HA. Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial. J Laryngol Otol 2010;124:397-401
3.
Zurück zum Zitat Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007;136:S107-24 Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 2007;136:S107-24
4.
Zurück zum Zitat Price D, Scadding G, Ryan D, Bachert C, Canonica GW, Mullol J et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy 2015;5:39 Price D, Scadding G, Ryan D, Bachert C, Canonica GW, Mullol J et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy 2015;5:39
5.
Zurück zum Zitat Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62:17-25 Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62:17-25
6.
Zurück zum Zitat Dalal AA, Stanford R, Henry H, Borah B. Economic burden of rhinitis in managed care: a retrospective claims data analysis. Ann Allergy Asthma Immunol 2008;101:23-9 Dalal AA, Stanford R, Henry H, Borah B. Economic burden of rhinitis in managed care: a retrospective claims data analysis. Ann Allergy Asthma Immunol 2008;101:23-9
7.
Zurück zum Zitat Anolik R; Mometasone Furoate Nasal Spray with Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:264-71 Anolik R; Mometasone Furoate Nasal Spray with Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:264-71
8.
Zurück zum Zitat Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Bianco CL et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004;34:259-67 Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Bianco CL et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004;34:259-67
9.
Zurück zum Zitat Interdisziplinäre Arbeitsgruppe "Allergische Rhinitis" der Sektion HNO. Allergische Rhinokonjunktivitis: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI). Allergo J 2003;12:182-94 Interdisziplinäre Arbeitsgruppe "Allergische Rhinitis" der Sektion HNO. Allergische Rhinokonjunktivitis: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI). Allergo J 2003;12:182-94
10.
Zurück zum Zitat Ratner PH, Ehrlich PM, Fineman SM, Meltzer EO, Skoner DP. Use of intranasal cromolyn sodium for allergic rhinitis. Mayo Clinic proceedings 2002;77:350-4 Ratner PH, Ehrlich PM, Fineman SM, Meltzer EO, Skoner DP. Use of intranasal cromolyn sodium for allergic rhinitis. Mayo Clinic proceedings 2002;77:350-4
11.
Zurück zum Zitat Lehtimaki L, Petays T, Haahtela T. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study. Int Arch Allergy Immunol 2009;149:150-3 Lehtimaki L, Petays T, Haahtela T. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study. Int Arch Allergy Immunol 2009;149:150-3
12.
Zurück zum Zitat Rodrigo GJ, Yanez A. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol 2006;96:779-86 Rodrigo GJ, Yanez A. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol 2006;96:779-86
13.
Zurück zum Zitat Kay GG, Quig ME. Impact of sedating antihistamines on safety and productivity. Allergy Asthma Proc 2001;22:281-3 Kay GG, Quig ME. Impact of sedating antihistamines on safety and productivity. Allergy Asthma Proc 2001;22:281-3
14.
Zurück zum Zitat Newson-Smith G, Powell M, Baehre M, Garnham SP, MacMahon MT. A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur Arch Otorhinolaryngol 1997;254:236-41 Newson-Smith G, Powell M, Baehre M, Garnham SP, MacMahon MT. A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur Arch Otorhinolaryngol 1997;254:236-41
15.
Zurück zum Zitat Yáñez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002;89:479-84 Yáñez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002;89:479-84
16.
Zurück zum Zitat Kaliner MA, Berger WE, Ratner PH, Siegel CJ. The efficacy of intranasal antihistamines in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2011;106:S6-11 Kaliner MA, Berger WE, Ratner PH, Siegel CJ. The efficacy of intranasal antihistamines in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2011;106:S6-11
17.
Zurück zum Zitat Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006;27:413-26 Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006;27:413-26
18.
Zurück zum Zitat Klimek L, Högger P, Pfaar O. Wirkmechanismen nasaler Glukokortikosteroide in der Therapie der allergischen Rhinitis. Teil 1: Pathophysiologie, molekulare Grundlagen. HNO 2012;60:611-7 Klimek L, Högger P, Pfaar O. Wirkmechanismen nasaler Glukokortikosteroide in der Therapie der allergischen Rhinitis. Teil 1: Pathophysiologie, molekulare Grundlagen. HNO 2012;60:611-7
19.
Zurück zum Zitat Okano M. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis. Clin Exp Immunol 2009;158:164-73 Okano M. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis. Clin Exp Immunol 2009;158:164-73
20.
Zurück zum Zitat Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol 2012;129:1282-9 Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol 2012;129:1282-9
21.
Zurück zum Zitat Hampel FC, Ratner PH, van Bavel J,Amar NJ, Daftary P, Wheeler W et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol 2010;105:168-73 Hampel FC, Ratner PH, van Bavel J,Amar NJ, Daftary P, Wheeler W et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol 2010;105:168-73
22.
Zurück zum Zitat Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc 2012;33:324-32 Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc 2012;33:324-32
23.
Zurück zum Zitat Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:74-81 Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:74-81
24.
Zurück zum Zitat Leung DYM, Szefler SJ. The Editors' Choice. J Allergy Clin Immunol 2012;129:1216-7 Leung DYM, Szefler SJ. The Editors' Choice. J Allergy Clin Immunol 2012;129:1216-7
Metadaten
Titel
Weisheiten aus dem Weißbuch - Kapitel 4.6
Pharmakotherapie bei allergischer Rhinitis und Asthma bronchiale
verfasst von
Prof. Dr. med. Ludger Klimek
Publikationsdatum
25.07.2022
Verlag
Springer Medizin
Erschienen in
Allergo Journal / Ausgabe 5/2022
Print ISSN: 0941-8849
Elektronische ISSN: 2195-6405
DOI
https://doi.org/10.1007/s15007-022-5060-5

Weitere Artikel der Ausgabe 5/2022

Allergo Journal 5/2022 Zur Ausgabe

Neu im Fachgebiet HNO

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update HNO und bleiben Sie gut informiert – ganz bequem per eMail.